Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0

I agree. I bought shares in this company before the panel meeting as this company's ability to train an individual's immune system to fight cancer truly hasĀ unbelievable potential. I viewed the investment as a once in a lifetime opportunity to invest in a company that might one day be a leader in the cancer treatment field.

While it's tempting for me to take the quick 300% gain, my more rational side tells me i'd be selling the next genentech for pennies on the dollar. I'm waiting until p-11 data matures, as Provenge's market could expand to billions and billions upon label expansion.

And i think their patented delivery system has the potential to produce many more therapies in the coming years...

I can't wait to watch this story unfold as well...

Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.